Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.
MMWR Surveill Summ. 2018 Feb 16;67(3):1-28. doi: 10.15585/mmwr.ss6703a1.
PROBLEM/CONDITION: Since the first U.S. infant conceived with assisted reproductive technology (ART) was born in 1981, both the use of ART and the number of fertility clinics providing ART services have increased steadily in the United States. ART includes fertility treatments in which eggs or embryos are handled in the laboratory (i.e., in vitro fertilization [IVF] and related procedures). Although the majority of infants conceived through ART are singletons, women who undergo ART procedures are more likely than women who conceive naturally to deliver multiple-birth infants. Multiple births pose substantial risks for both mothers and infants, including obstetric complications, preterm delivery (<37 weeks), and low birthweight (<2,500 g) infants. This report provides state-specific information for the United States (including the District of Columbia and Puerto Rico) on ART procedures performed in 2015 and compares birth outcomes that occurred in 2015 (resulting from ART procedures performed in 2014 and 2015) with outcomes for all infants born in the United States in 2015.
In 1995, CDC began collecting data on ART procedures performed in fertility clinics in the United States as mandated by the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA) (Public Law 102-493 [October 24, 1992]). Data are collected through the National ART Surveillance System, a web-based data collection system developed by CDC. This report includes data from 52 reporting areas (the 50 states, the District of Columbia, and Puerto Rico).
In 2015, a total of 182,111 ART procedures (range: 135 in Alaska to 23,198 in California) with the intent to transfer at least one embryo were performed in 464 U.S. fertility clinics and reported to CDC. These procedures resulted in 59,334 live-birth deliveries (range: 55 in Wyoming to 7,802 in California) and 71,152 infants born (range: 68 in Wyoming to 9,176 in California). Nationally, the number of ART procedures performed per 1 million women of reproductive age (15-44 years), a proxy measure of the ART utilization rate, was 2,832. ART use exceeded the national rate in 13 reporting areas (California, Connecticut, Delaware, the District of Columbia, Hawaii, Illinois, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Rhode Island, and Virginia). Nationally, among ART transfer procedures in patients using fresh embryos from their own eggs, the average number of embryos transferred increased with increasing age of the woman (1.6 among women aged <35 years, 1.8 among women aged 35-37 years, and 2.3 among women aged >37 years). Among women aged <35 years, the national elective single-embryo transfer (eSET) rate was 34.7% (range: 11.3% in Puerto Rico to 88.1% in Delaware). In 2015, ART contributed to 1.7% of all infants born in the United States (range: 0.3% in Puerto Rico to 4.5% in Massachusetts). ART also contributed to 17.0% of all multiple-birth infants, 16.8% of all twin infants, and 22.2% of all triplets and higher-order infants. The percentage of multiple-birth infants was higher among infants conceived with ART (35.3%) than among all infants born in the total birth population (3.4%). Approximately 34.0% of ART-conceived infants were twins and 1.0% were triplets and higher-order infants. Nationally, infants conceived with ART contributed to 5.1% of all low birthweight infants. Among ART-conceived infants, 25.5% had low birthweight, compared with 8.1% among all infants. ART-conceived infants contributed to 5.3% of all preterm (gestational age <37 weeks) infants. The percentage of preterm births was higher among infants conceived with ART (31.2%) than among all infants born in the total birth population (9.7%). Among singletons, the percentage of ART-conceived infants who had low birthweight was 8.7% compared with 6.4% among all infants born. The percentage of ART-conceived infants who were born preterm was 13.4% among singletons compared with 7.9% among all infants.
Multiple births from ART contributed to a substantial proportion of all twins, triplets, and higher-order infants born in the United States. For women aged <35 years, who are typically considered good candidates for eSET, the national average of 1.6 embryos was transferred per ART procedure. Of the four states (Illinois, Massachusetts, New Jersey, and Rhode Island) with comprehensive mandated health insurance coverage for ART procedures (i.e., coverage for at least four cycles of IVF), three (Illinois, Massachusetts, and New Jersey) had rates of ART use exceeding 1.5 times the national rate. This type of mandated insurance coverage has been associated with greater use of ART and likely accounts for some of the difference in per capita ART use observed among states.
Twins account for the majority of ART-conceived multiple births. Reducing the number of embryos transferred and increasing use of eSET when clinically appropriate could help reduce multiple births and related adverse health consequences for both mothers and infants. State-based surveillance of ART might be useful for monitoring and evaluating maternal and infant health outcomes of ART in states with high ART use.
问题/状况:自 1981 年美国首例通过辅助生殖技术(ART)受孕的婴儿出生以来,ART 的使用以及提供 ART 服务的生育诊所数量在美国稳步增加。ART 包括在实验室中处理卵子或胚胎的生育治疗(即体外受精 [IVF] 和相关程序)。尽管通过 ART 受孕的大多数婴儿是单胎,但接受 ART 程序的女性比自然受孕的女性更有可能分娩多胎婴儿。多胎妊娠会给母亲和婴儿带来巨大的风险,包括产科并发症、早产(<37 周)和低出生体重(<2500 克)婴儿。本报告提供了美国(包括哥伦比亚特区和波多黎各) 2015 年 ART 程序的州特定信息,并比较了 2015 年(由 2014 年和 2015 年进行的 ART 程序产生)的出生结果与 2015 年美国所有婴儿的出生结果。
2015 年。
1995 年,CDC 根据 1992 年《生育诊所成功率和认证法案》(FCSRCA)(公法 102-493 [1992 年 10 月 24 日])开始收集美国生育诊所进行的 ART 程序数据。数据通过 CDC 开发的基于网络的数据收集系统国家 ART 监测系统收集。本报告包括来自 52 个报告地区(50 个州、哥伦比亚特区和波多黎各)的数据。
2015 年,美国 464 家生育诊所共进行了 182111 次(范围:阿拉斯加 135 次至加利福尼亚州 23198 次)有至少一个胚胎转移意向的 ART 程序,并向 CDC 报告。这些程序导致 59334 次活产分娩(范围:怀俄明州 55 次至加利福尼亚州 7802 次)和 71152 名婴儿出生(范围:怀俄明州 68 次至加利福尼亚州 9176 次)。全国范围内,每 100 万育龄妇女(15-44 岁)进行的 ART 程序数量,即 ART 利用率的代理指标,为 2832 次。在 13 个报告地区(加利福尼亚州、康涅狄格州、特拉华州、哥伦比亚特区、夏威夷州、伊利诺伊州、马里兰州、马萨诸塞州、新罕布什尔州、新泽西州、纽约州、罗得岛州和弗吉尼亚州),ART 的使用超过了全国水平。在使用自身卵子的新鲜胚胎进行胚胎转移的 ART 转移程序中,女性年龄越大,转移的胚胎数量就越多(<35 岁的女性为 1.6 个,35-37 岁的女性为 1.8 个,>37 岁的女性为 2.3 个)。在<35 岁的女性中,全国选择性单胚胎移植(eSET)率为 34.7%(范围:波多黎各 11.3%至特拉华州 88.1%)。2015 年,ART 占美国出生婴儿的 1.7%(范围:波多黎各 0.3%至马萨诸塞州 4.5%)。ART 还占所有多胎婴儿的 17.0%、所有双胞胎的 16.8%和所有三胞胎及以上婴儿的 22.2%。多胎婴儿的比例在接受 ART 受孕的婴儿中(35.3%)高于总出生人口中的所有婴儿(3.4%)。大约 34.0%的 ART 受孕婴儿是双胞胎,1.0%是三胞胎及以上婴儿。全国范围内,ART 受孕婴儿占所有低出生体重婴儿的 5.1%。在 ART 受孕的婴儿中,25.5%体重低,而所有婴儿中这一比例为 8.1%。ART 受孕婴儿占所有早产(<37 周)婴儿的 5.3%。早产儿的比例在接受 ART 受孕的婴儿中(31.2%)高于总出生人口中的所有婴儿(9.7%)。在单胎中,体重低的 ART 受孕婴儿的比例为 8.7%,而所有婴儿的这一比例为 6.4%。ART 受孕婴儿早产的比例为 13.4%,而所有婴儿的这一比例为 7.9%。
ART 多胎妊娠导致美国出生的双胞胎、三胞胎和更高比例的婴儿数量显著增加。对于年龄<35 岁的女性,通常被认为是 eSET 的良好候选者,每例 ART 程序平均转移 1.6 个胚胎。在四个(伊利诺伊州、马萨诸塞州、新泽西州和罗得岛州)有全面强制性医疗保险覆盖 ART 程序(即至少覆盖四个周期的 IVF)的州中,有三个(伊利诺伊州、马萨诸塞州和新泽西州)的 ART 使用率超过全国水平的 1.5 倍。这种强制性保险覆盖范围与 ART 的更多使用有关,可能是造成各州之间人均 ART 使用差异的部分原因。
双胞胎占 ART 多胎妊娠的大部分。减少胚胎转移数量并在临床可行时增加 eSET 的使用,可以帮助减少多胎妊娠及其对母婴的相关不良健康后果。基于州的 ART 监测可能有助于监测和评估高 ART 使用率州的 ART 对母婴健康结局的影响。